--- Chain 13 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 3806
Reasoning Tokens (Counted): 3185
Non-Reasoning Tokens (Counted): 619
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this pretty complex question about molecular biology, specifically dealing with vectors and gene expression. Let me try to break this down step by step.

Alright, the setup is that there's a new ligand-receptor pair found in neural crest cells, and we're trying to figure out their developmental fate. The question revolves around a bicistronic vector they created. 

So, bicistronic means it has two ORFs (open reading frames) in one vector. The vector is a lox-Cre construct. The ligand's ORF is at the 5' end and is fused to mCherry. The receptor's ORF is at the 3' end and fused to eGFP at the C-terminus. 

The ligand is under the CBA promoter. Upstream of the receptor is an IRES regulatory element. There are stop cassettes with loxP and lox2272. So between ligand and mCherry, there's a loxP-stop-loxP cassette. Between receptor and eGFP, it's lox2272-stop-lox2272. 

They made antibodies against the overexpressed proteins and tested expression via Western blot. Then they made a mouse model homozygous for the construct in a wild-type background. They crossed it with SOX10-Cre mice. After the offspring are born, they looked for green signal under confocal. No green observed. Why?

The options are about possible issues in expression.

First, I'm thinking about how the bicistronic vector works. With a lox-Cre system, the idea is that Cre recombinase will excise the stop cassettes. So, when Cre is expressed, it should remove the stop cassettes, allowing the two ORFs (ligand and receptor) to be expressed.

In this case, the vector has ligand (CBA-driven) followed by a stop cassette (loxP-based), then maybe a start for the receptor? Or is the receptor under a different promoter? Wait, the ligand is under the CBA promoter, and the receptor is after an IRES element. IRES elements allow for internal ribosome entry, so perhaps the receptor is expressed as a separate ORF under the same promoter. Or maybe the CBA promoter drives both, but the IRES allows for expression of the receptor after the ligand? Hmm, not entirely sure. 

Wait, here's the structure of the vector:

5' - [CBA promoter] - [ligand ORF] - [loxP-stop-loxP cassette] - [mCherry] - ... and then perhaps another promoter or IRES.

Wait, the setup says the ligand is at 5' with mCherry, and the receptor is at 3' with eGFP. The ligand is under CBA promoter; upstream of receptor is IRES. So perhaps the vector has the ligand and receptor under a single promoter, with the ligand being first, and the receptor being after an IRES. But the stop cassettes complicate things.

Alternatively, maybe the vector is designed to allow for expression of either ligand plus mCherry, or receptor plus eGFP, depending on Cre. Because the stop cassettes are flanked by lox sites. So in the absence of Cre, the ligand is expressed with mCherry, and the receptor is not expressed because the stop cassette blocks it. When Cre is present, it removes the stop cassettes, allowing the receptor to be expressed with eGFP.

Wait, but that might not be the case. Let me think again. The vector is bicistronic, meaning it's set up to express two proteins. The ligand is under the CBA promoter, so that's the first ORF. The second ORF is the receptor, which is after an IRES. So, the CBA promoter would drive the transcription of a mRNA that has both ORFs. The IRES would allow for the receptor to be translated separately, perhaps allowing both ligand and receptor to be expressed from the same mRNA.

But the stop cassettes complicate this. The ligand ORF is followed by a stop cassette (loxP-stop-loxP). So in the absence of Cre, the transcript would have the ligand, then the stop, so the mRNA would terminate there, and the receptor wouldn't be expressed. But wait, the IRES is upstream of the receptor. So perhaps without Cre, the ligand is expressed with mCherry, and the receptor isn't because the stop cassette is in the way. When Cre is introduced, it excises the loxP sites, removing the stop, allowing the receptor to be expressed with eGFP.

So, the setup is that the vector can express ligand plus mCherry, or upon Cre, it expresses both ligand (with mCherry) and receptor (with eGFP). Wait, but the question says that after making homozygous mice, they crossed them to SOX10-Cre mice. SOX10 is expressed in neural crest cells, so the Cre would be active there. So in the offspring, the Cre would excise the stop cassettes, allowing both ligand and receptor to be expressed.

But in the Western blot, they tested the expression after transfection into primary astrocyte culture. Maybe Cre wasn't active there, so only the ligand with mCherry would be expressed. Or perhaps the construct is designed so that without Cre, only the ligand is expressed, and with Cre, both are expressed.

But wait, the mouse model is homozygous, and they crossed to SOX10-Cre. So the Cre is present, so the stop cassettes would be removed. But the result is that there's no green signal (eGFP) in the confocal. So why isn't the receptor-eGFP being expressed?

Looking at the options:

A) ligand and receptor are paracrine: meaning they act on different cells. But the question is about expression, not function. Maybe the expression is in the same cell, so this might not explain the lack of green.

B) Receptor-eGFP stuck in Golgi. So the protein isn't getting to the cell surface. But the Western blot would show the protein, just not in the right place. But the question says the Western blot used total proteins, so if the protein is present, it would show up. So if the eGFP-Receptor is made but not secreted, but the Western blot would still detect it. So maybe not this.

C) Enhancer for expression is missing. The ligand is under CBA promoter; perhaps the enhancer is missing, so the ligand isn't expressed. But the vector should have the CBA promoter which is strong. Also, the question says that they did a Western blot after transfection and saw signals proportional to actin. So the antibodies worked. So perhaps the issue is that the receptor isn't expressed.

D) The receptor and eGFP are not in frame. So when the stop cassette is removed, the ORF for the receptor might not be correctly in frame with eGFP. So the eGFP wouldn't be properly expressed, or the receptor might be truncated, leading to no functional eGFP. So when they look for eGFP fluorescence, they don't see it.

So the vector has the ligand ORF with mCherry, but the stop cassette blocks the receptor. When Cre is introduced (from SOX10-Cre mice), the loxP sites are recombined, excising the stop cassette. So the receptor is expressed, but is it correctly in frame with eGFP?

Wait, the vector is set up so that the receptor's ORF is followed by a stop cassette with lox2272. So without Cre, the receptor isn't expressed because the stop is in place. With Cre, the stop is removed, so the receptor's ORF is expressed, and perhaps eGFP is part of the construct after the receptor? Or is the eGFP in frame with the receptor?

Wait, the vector's structure as per the question is:

Ligand ORF at 5', fused to mCherry. The ligand is under the CBA promoter. Then there's a loxP-stop-loxP cassette. Then the receptor ORF is at 3', and it's fused to eGFP at the C-terminus. So the ligand is in frame with mCherry.

Wait, that's a bit confusing. Let me try to visualize it:

5' - [CBA promoter] - [ligand ORF] - [stop cassette (loxP-stop-loxP)] - [mCherry] ... ?

Wait, no, perhaps the ligand is followed by a stop, but the stop is a loxP cassette. So without Cre, the ligand's ORF ends at the stop, and the rest (mCherry) isn't expressed. When Cre is present, the stop is removed, so the mCherry is expressed along with the ligand.

But that's the ligand's part. The receptor is at the 3' end, with its own IRES element. Or maybe the vector is designed so that when Cre is present, the stop cassettes are removed, and both ligand and receptor are expressed.

Wait, I'm getting a bit confused. Let me think about each part:

- Ligand ORF is at 5', fused to mCherry. So the ligand is expressed with mCherry as a fusion protein. But between the ligand ORF and mCherry, there's a stop cassette (loxP-stop-loxP). So without Cre, the ligand is expressed but mCherry is not. With Cre, the stop is removed, so the ligand is expressed along with mCherry.

- Similarly, the receptor ORF is at 3', fused to eGFP. Between the receptor and eGFP is a stop cassette with lox2272. So without Cre, the receptor is expressed but eGFP isn't. With Cre, the stop is removed, so receptor and eGFP are expressed together.

Wait, that makes sense. So the vector is set up such that Cre deletes both stops, allowing both ligand-mCherry and receptor-eGFP to be expressed. But the question is, in the experiment, when they use SOX10-Cre, the eGFP isn't observed.

But the problem says that after transfecting the plasmid into astrocytes, they used Western blot. So if the vector is transfected, and Cre is not present (since it's in the mice but not in the culture?), then in the Western blot, only the ligand-mCherry would be expressed. But I'm not too sure about that part.

Wait, the vector is a bicistronic lox-Cre vector. So the plasmid is present in the cells. But Cre is only present in the mice when they have the SOX10-Cre transgene. So when they transfected the plasmid into primary astrocytes, the cells wouldn't have Cre, so the stops would remain, and only ligand-mCherry and perhaps the receptor without eGFP? Or maybe the receptor is under IRES and is expressed regardless.

Wait, no. Without Cre, the ligand's ORF would end at the loxP-stop, so mCherry wouldn't be expressed. But the receptor's ORF would have the lox2272 stop. So without Cre, the receptor is expressed, but eGFP isn't. So in the Western blot, they'd see the receptor but not eGFP.

But the question says that the mouse is homozygous for the construct, crossed with SOX10-Cre. The SOX10-Cre would mean that in the neural crest cells, Cre is active, so the stops are removed, allowing both mCherry and eGFP to be expressed.

Wait, but the expression is in the mouse. They're looking for eGFP in the offspring. But they don't see any green signal. So perhaps the receptor-eGFP isn't being expressed.

So why would that be? Let's look back at the options.

Option D says the receptor and eGFP are not in frame. So the construct for the receptor is such that when the stop is removed, the ORF of the receptor is not in frame with eGFP. So when Cre is present, the receptor is expressed, but the eGFP isn't because the frameshift causes a premature stop or the eGFP isn't correctly translated.

Alternatively, maybe the eGFP is not correctly cloned in frame with the receptor. So when the stop is removed, the receptor is made, but the eGFP isn't. So when they look for eGFP, it's not present.

So in the Western blot, when they transfected the plasmid, without Cre, the receptor would be expressed without eGFP. After Cre is added (in the mouse), the eGFP should be expressed. But in the mouse, they don't see eGFP. So the problem is that the eGFP isn't being expressed.

So the issue could be that the eGFP is not in frame, leading to no expression.

Alternatively, another option is that the enhancer is missing. But the ligand is under CBA, a strong promoter. Maybe the receptor's expression depends on the IRES, but without the correct enhancer, it's not expressed.

But the question says that the vector includes the IRES upstream of the receptor, so perhaps the IRES should drive expression regardless. But I'm not sure.

Hmm, another possibility is that the IRES isn't working correctly, so the receptor isn't being expressed. But the question doesn't mention anything about that.

Alternatively, when the stop cassette is removed, the eGFP isn't being expressed because the frame is wrong. So why would the frame be wrong? Because the stop cassette removal could disrupt the reading frame.

Wait, the loxP and lox2272 sites are recognition sites for Cre. When Cre acts, it excises the stop cassette, which is flanked by loxP sites, or in the other case, lox2272. So for the stop cassette between ligand and mCherry, which is loxP-stop-loxP, Cre would excise that, allowing the ligand and mCherry to be expressed together. Similarly, the stop cassette between receptor and eGFP is lox2272, so Cre would excise that, allowing receptor and eGFP to be expressed together.

But if the frames aren't aligned, then when the stop is removed, the reading frame of the receptor and eGFP isn't in phase. So the receptor would be expressed, but eGFP might not be, or the entire construct could produce a nonfunctional protein.

In that case, the eGFP wouldn't be expressed, leading to no green signal.

So option D would be the correct answer.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector designed to express a ligand and receptor pair, with mCherry fused to the ligand and eGFP fused to the receptor. The ligand is under the CBA promoter, and the receptor is upstream of an IRES element. Stop cassettes (loxP-stop-loxP and lox2272-stop-lox2272) are present between the ligand and mCherry, and between the receptor and eGFP, respectively. Cre recombinase, provided by SOX10-Cre mice, is expected to excise these stop cassettes, allowing both ligand-mCherry and receptor-eGFP to be expressed. However, no green signal (eGFP) is observed in the confocal microscopy of offspring mice.

### Key Analysis:
1. **Vector Design and Function**:
   - Without Cre, the stop cassettes block expression of mCherry and eGFP. The ligand and receptor may still be expressed, but not fused to mCherry or eGFP.
   - With Cre, the stop cassettes are excised, allowing ligand-mCherry and receptor-eGFP to be expressed.

2. **Experimental Setup**:
   - The mouse model is homozygous for the construct, and SOX10-Cre mice are used to provide Cre recombinase, particularly in neural crest cells where SOX10 is expressed.
   - The absence of a green signal suggests that receptor-eGFP is not being expressed.

3. **Critical Evaluation of Options**:
   - **(A) Paracrine relationship**: This refers to the functional interaction between ligand and receptor, not their expression. The question focuses on expression, so this does not explain the lack of green signal.
   - **(B) Receptor-eGFP stuck in the Golgi**: If receptor-eGFP were mislocalized, it would still be detectable via Western blot. Since no green signal is observed, the issue is likely at the expression level, not localization.
   - **(C) Missing enhancer for expression**: The ligand is under the CBA promoter, which is strong and sufficient for expression. The receptor is upstream of an IRES element, which should allow its expression independently. There is no evidence of a missing enhancer in the construct.
   - **(D) Receptor and eGFP not in frame**: If the receptor and eGFP are not in frame, Cre excision of the stop cassette would not result in proper eGFP expression. This would lead to the receptor being expressed without eGFP, explaining the absence of a green signal.

### Conclusion:
The most likely explanation is that the receptor and eGFP are not in frame, preventing proper eGFP expression even after Cre excision of the stop cassette. This aligns with the observation of no green signal in the confocal microscopy.

**Answer: D**

--- Full Content ---
Okay, so I've got this pretty complex question about molecular biology, specifically dealing with vectors and gene expression. Let me try to break this down step by step.

Alright, the setup is that there's a new ligand-receptor pair found in neural crest cells, and we're trying to figure out their developmental fate. The question revolves around a bicistronic vector they created. 

So, bicistronic means it has two ORFs (open reading frames) in one vector. The vector is a lox-Cre construct. The ligand's ORF is at the 5' end and is fused to mCherry. The receptor's ORF is at the 3' end and fused to eGFP at the C-terminus. 

The ligand is under the CBA promoter. Upstream of the receptor is an IRES regulatory element. There are stop cassettes with loxP and lox2272. So between ligand and mCherry, there's a loxP-stop-loxP cassette. Between receptor and eGFP, it's lox2272-stop-lox2272. 

They made antibodies against the overexpressed proteins and tested expression via Western blot. Then they made a mouse model homozygous for the construct in a wild-type background. They crossed it with SOX10-Cre mice. After the offspring are born, they looked for green signal under confocal. No green observed. Why?

The options are about possible issues in expression.

First, I'm thinking about how the bicistronic vector works. With a lox-Cre system, the idea is that Cre recombinase will excise the stop cassettes. So, when Cre is expressed, it should remove the stop cassettes, allowing the two ORFs (ligand and receptor) to be expressed.

In this case, the vector has ligand (CBA-driven) followed by a stop cassette (loxP-based), then maybe a start for the receptor? Or is the receptor under a different promoter? Wait, the ligand is under the CBA promoter, and the receptor is after an IRES element. IRES elements allow for internal ribosome entry, so perhaps the receptor is expressed as a separate ORF under the same promoter. Or maybe the CBA promoter drives both, but the IRES allows for expression of the receptor after the ligand? Hmm, not entirely sure. 

Wait, here's the structure of the vector:

5' - [CBA promoter] - [ligand ORF] - [loxP-stop-loxP cassette] - [mCherry] - ... and then perhaps another promoter or IRES.

Wait, the setup says the ligand is at 5' with mCherry, and the receptor is at 3' with eGFP. The ligand is under CBA promoter; upstream of receptor is IRES. So perhaps the vector has the ligand and receptor under a single promoter, with the ligand being first, and the receptor being after an IRES. But the stop cassettes complicate things.

Alternatively, maybe the vector is designed to allow for expression of either ligand plus mCherry, or receptor plus eGFP, depending on Cre. Because the stop cassettes are flanked by lox sites. So in the absence of Cre, the ligand is expressed with mCherry, and the receptor is not expressed because the stop cassette blocks it. When Cre is present, it removes the stop cassettes, allowing the receptor to be expressed with eGFP.

Wait, but that might not be the case. Let me think again. The vector is bicistronic, meaning it's set up to express two proteins. The ligand is under the CBA promoter, so that's the first ORF. The second ORF is the receptor, which is after an IRES. So, the CBA promoter would drive the transcription of a mRNA that has both ORFs. The IRES would allow for the receptor to be translated separately, perhaps allowing both ligand and receptor to be expressed from the same mRNA.

But the stop cassettes complicate this. The ligand ORF is followed by a stop cassette (loxP-stop-loxP). So in the absence of Cre, the transcript would have the ligand, then the stop, so the mRNA would terminate there, and the receptor wouldn't be expressed. But wait, the IRES is upstream of the receptor. So perhaps without Cre, the ligand is expressed with mCherry, and the receptor isn't because the stop cassette is in the way. When Cre is introduced, it excises the loxP sites, removing the stop, allowing the receptor to be expressed with eGFP.

So, the setup is that the vector can express ligand plus mCherry, or upon Cre, it expresses both ligand (with mCherry) and receptor (with eGFP). Wait, but the question says that after making homozygous mice, they crossed them to SOX10-Cre mice. SOX10 is expressed in neural crest cells, so the Cre would be active there. So in the offspring, the Cre would excise the stop cassettes, allowing both ligand and receptor to be expressed.

But in the Western blot, they tested the expression after transfection into primary astrocyte culture. Maybe Cre wasn't active there, so only the ligand with mCherry would be expressed. Or perhaps the construct is designed so that without Cre, only the ligand is expressed, and with Cre, both are expressed.

But wait, the mouse model is homozygous, and they crossed to SOX10-Cre. So the Cre is present, so the stop cassettes would be removed. But the result is that there's no green signal (eGFP) in the confocal. So why isn't the receptor-eGFP being expressed?

Looking at the options:

A) ligand and receptor are paracrine: meaning they act on different cells. But the question is about expression, not function. Maybe the expression is in the same cell, so this might not explain the lack of green.

B) Receptor-eGFP stuck in Golgi. So the protein isn't getting to the cell surface. But the Western blot would show the protein, just not in the right place. But the question says the Western blot used total proteins, so if the protein is present, it would show up. So if the eGFP-Receptor is made but not secreted, but the Western blot would still detect it. So maybe not this.

C) Enhancer for expression is missing. The ligand is under CBA promoter; perhaps the enhancer is missing, so the ligand isn't expressed. But the vector should have the CBA promoter which is strong. Also, the question says that they did a Western blot after transfection and saw signals proportional to actin. So the antibodies worked. So perhaps the issue is that the receptor isn't expressed.

D) The receptor and eGFP are not in frame. So when the stop cassette is removed, the ORF for the receptor might not be correctly in frame with eGFP. So the eGFP wouldn't be properly expressed, or the receptor might be truncated, leading to no functional eGFP. So when they look for eGFP fluorescence, they don't see it.

So the vector has the ligand ORF with mCherry, but the stop cassette blocks the receptor. When Cre is introduced (from SOX10-Cre mice), the loxP sites are recombined, excising the stop cassette. So the receptor is expressed, but is it correctly in frame with eGFP?

Wait, the vector is set up so that the receptor's ORF is followed by a stop cassette with lox2272. So without Cre, the receptor isn't expressed because the stop is in place. With Cre, the stop is removed, so the receptor's ORF is expressed, and perhaps eGFP is part of the construct after the receptor? Or is the eGFP in frame with the receptor?

Wait, the vector's structure as per the question is:

Ligand ORF at 5', fused to mCherry. The ligand is under the CBA promoter. Then there's a loxP-stop-loxP cassette. Then the receptor ORF is at 3', and it's fused to eGFP at the C-terminus. So the ligand is in frame with mCherry.

Wait, that's a bit confusing. Let me try to visualize it:

5' - [CBA promoter] - [ligand ORF] - [stop cassette (loxP-stop-loxP)] - [mCherry] ... ?

Wait, no, perhaps the ligand is followed by a stop, but the stop is a loxP cassette. So without Cre, the ligand's ORF ends at the stop, and the rest (mCherry) isn't expressed. When Cre is present, the stop is removed, so the mCherry is expressed along with the ligand.

But that's the ligand's part. The receptor is at the 3' end, with its own IRES element. Or maybe the vector is designed so that when Cre is present, the stop cassettes are removed, and both ligand and receptor are expressed.

Wait, I'm getting a bit confused. Let me think about each part:

- Ligand ORF is at 5', fused to mCherry. So the ligand is expressed with mCherry as a fusion protein. But between the ligand ORF and mCherry, there's a stop cassette (loxP-stop-loxP). So without Cre, the ligand is expressed but mCherry is not. With Cre, the stop is removed, so the ligand is expressed along with mCherry.

- Similarly, the receptor ORF is at 3', fused to eGFP. Between the receptor and eGFP is a stop cassette with lox2272. So without Cre, the receptor is expressed but eGFP isn't. With Cre, the stop is removed, so receptor and eGFP are expressed together.

Wait, that makes sense. So the vector is set up such that Cre deletes both stops, allowing both ligand-mCherry and receptor-eGFP to be expressed. But the question is, in the experiment, when they use SOX10-Cre, the eGFP isn't observed.

But the problem says that after transfecting the plasmid into astrocytes, they used Western blot. So if the vector is transfected, and Cre is not present (since it's in the mice but not in the culture?), then in the Western blot, only the ligand-mCherry would be expressed. But I'm not too sure about that part.

Wait, the vector is a bicistronic lox-Cre vector. So the plasmid is present in the cells. But Cre is only present in the mice when they have the SOX10-Cre transgene. So when they transfected the plasmid into primary astrocytes, the cells wouldn't have Cre, so the stops would remain, and only ligand-mCherry and perhaps the receptor without eGFP? Or maybe the receptor is under IRES and is expressed regardless.

Wait, no. Without Cre, the ligand's ORF would end at the loxP-stop, so mCherry wouldn't be expressed. But the receptor's ORF would have the lox2272 stop. So without Cre, the receptor is expressed, but eGFP isn't. So in the Western blot, they'd see the receptor but not eGFP.

But the question says that the mouse is homozygous for the construct, crossed with SOX10-Cre. The SOX10-Cre would mean that in the neural crest cells, Cre is active, so the stops are removed, allowing both mCherry and eGFP to be expressed.

Wait, but the expression is in the mouse. They're looking for eGFP in the offspring. But they don't see any green signal. So perhaps the receptor-eGFP isn't being expressed.

So why would that be? Let's look back at the options.

Option D says the receptor and eGFP are not in frame. So the construct for the receptor is such that when the stop is removed, the ORF of the receptor is not in frame with eGFP. So when Cre is present, the receptor is expressed, but the eGFP isn't because the frameshift causes a premature stop or the eGFP isn't correctly translated.

Alternatively, maybe the eGFP is not correctly cloned in frame with the receptor. So when the stop is removed, the receptor is made, but the eGFP isn't. So when they look for eGFP, it's not present.

So in the Western blot, when they transfected the plasmid, without Cre, the receptor would be expressed without eGFP. After Cre is added (in the mouse), the eGFP should be expressed. But in the mouse, they don't see eGFP. So the problem is that the eGFP isn't being expressed.

So the issue could be that the eGFP is not in frame, leading to no expression.

Alternatively, another option is that the enhancer is missing. But the ligand is under CBA, a strong promoter. Maybe the receptor's expression depends on the IRES, but without the correct enhancer, it's not expressed.

But the question says that the vector includes the IRES upstream of the receptor, so perhaps the IRES should drive expression regardless. But I'm not sure.

Hmm, another possibility is that the IRES isn't working correctly, so the receptor isn't being expressed. But the question doesn't mention anything about that.

Alternatively, when the stop cassette is removed, the eGFP isn't being expressed because the frame is wrong. So why would the frame be wrong? Because the stop cassette removal could disrupt the reading frame.

Wait, the loxP and lox2272 sites are recognition sites for Cre. When Cre acts, it excises the stop cassette, which is flanked by loxP sites, or in the other case, lox2272. So for the stop cassette between ligand and mCherry, which is loxP-stop-loxP, Cre would excise that, allowing the ligand and mCherry to be expressed together. Similarly, the stop cassette between receptor and eGFP is lox2272, so Cre would excise that, allowing receptor and eGFP to be expressed together.

But if the frames aren't aligned, then when the stop is removed, the reading frame of the receptor and eGFP isn't in phase. So the receptor would be expressed, but eGFP might not be, or the entire construct could produce a nonfunctional protein.

In that case, the eGFP wouldn't be expressed, leading to no green signal.

So option D would be the correct answer.


The question involves a bicistronic lox-Cre vector designed to express a ligand and receptor pair, with mCherry fused to the ligand and eGFP fused to the receptor. The ligand is under the CBA promoter, and the receptor is upstream of an IRES element. Stop cassettes (loxP-stop-loxP and lox2272-stop-lox2272) are present between the ligand and mCherry, and between the receptor and eGFP, respectively. Cre recombinase, provided by SOX10-Cre mice, is expected to excise these stop cassettes, allowing both ligand-mCherry and receptor-eGFP to be expressed. However, no green signal (eGFP) is observed in the confocal microscopy of offspring mice.

### Key Analysis:
1. **Vector Design and Function**:
   - Without Cre, the stop cassettes block expression of mCherry and eGFP. The ligand and receptor may still be expressed, but not fused to mCherry or eGFP.
   - With Cre, the stop cassettes are excised, allowing ligand-mCherry and receptor-eGFP to be expressed.

2. **Experimental Setup**:
   - The mouse model is homozygous for the construct, and SOX10-Cre mice are used to provide Cre recombinase, particularly in neural crest cells where SOX10 is expressed.
   - The absence of a green signal suggests that receptor-eGFP is not being expressed.

3. **Critical Evaluation of Options**:
   - **(A) Paracrine relationship**: This refers to the functional interaction between ligand and receptor, not their expression. The question focuses on expression, so this does not explain the lack of green signal.
   - **(B) Receptor-eGFP stuck in the Golgi**: If receptor-eGFP were mislocalized, it would still be detectable via Western blot. Since no green signal is observed, the issue is likely at the expression level, not localization.
   - **(C) Missing enhancer for expression**: The ligand is under the CBA promoter, which is strong and sufficient for expression. The receptor is upstream of an IRES element, which should allow its expression independently. There is no evidence of a missing enhancer in the construct.
   - **(D) Receptor and eGFP not in frame**: If the receptor and eGFP are not in frame, Cre excision of the stop cassette would not result in proper eGFP expression. This would lead to the receptor being expressed without eGFP, explaining the absence of a green signal.

### Conclusion:
The most likely explanation is that the receptor and eGFP are not in frame, preventing proper eGFP expression even after Cre excision of the stop cassette. This aligns with the observation of no green signal in the confocal microscopy.

**Answer: D**